Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 2Vulvar Diseases 1Uterine Cervical Dysplasia 1

Interventions

Conization 3Papillomavirus Vaccines 2Human Papillomavirus DNA Tests 2Colposcopy 2pembrolizumab 1epigallocatechin gallate 1artesunic acid 1artemisinin 1Watchful Waiting 1Transurethral Resection of Prostate 1Restraint, Physical 1Pregnancy Tests 1Liquid Biopsy 1Imiquimod 1Hysterectomy 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Fenofibrate 1Chemoradiotherapy 1Blood Specimen Collection 1Biopsy 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Uterine Cervical Dysplasia × artemisinin × Clear all
NCT04098744 2025-10-02

ART-CIN_IIB

Frantz Viral Therapeutics, LLC

Phase 2 Recruiting
78 enrolled
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡